Providing physicians with virtual access to specialists can be lifesaving to liver disease patients. A new study finds that it boosts survival rates by 54 percent.
Rosemary (Rosie) Clandos is a contributing health and science writer. She has written for the Los Angeles Times, Kaiser Permanente, U.S. Department of Defense, National Science Foundation, and several universities and medical centers on the West Coast. Rosie has covered topics ranging from medicine to microelectromechanical systems. As the author of “Health Hunt on the Internet: Find and Use Reliable Medical Information,” she specializes in compelling storytelling.
Successfully tested in mice, targeted drug and gene therapies might one day benefit patients with a deadly lung disease, new U-M research finds.
Immunotherapy cancer drugs can cause a potentially vision-robbing side effect. In a new report, Michigan Medicine experts discuss the risks and what oncologists should know.
A new review of private insurance data finds that alcohol is a major contributor to cirrhosis cases — and that women drinkers are disproportionately af
The novel platform for chemoimmunotherapy eliminated colon cancer in 85 percent of treated mice.
New research documents how chemicals and a certain gene activate an enzyme to increase the risk and severity of RA and bone destruction.